Long-term changes in cardiovascular risk markers during administration of exenatide twice daily or glimepiride: results from the European exenatide study

OBJECTIVE: The risk of cardiovascular morbidity and mortality is significantly increased in patients with diabetes; thus, it is important to determine whether glucose-lowering therapy affects this risk over time. Changes in cardiovascular risk markers were examined in patients with type 2 diabetes t...

Descripción completa

Detalles Bibliográficos
Autores principales: Simó, Rafael, Guerci, Bruno, Schernthaner, Guntram, Gallwitz, Baptist, Rosas-Guzmàn, Juan, Dotta, Francesco, Festa, Andreas, Zhou, Ming, Kiljański, Jacek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558893/
https://www.ncbi.nlm.nih.gov/pubmed/26338040
http://dx.doi.org/10.1186/s12933-015-0279-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558893/
https://www.ncbi.nlm.nih.gov/pubmed/26338040
http://dx.doi.org/10.1186/s12933-015-0279-z

Ejemplares similares